Tumor size and prognosis in aggressively treated osteosarcoma.
P. Bieling(Universität Hamburg), K. Winkler, R. Maas(Universität Hamburg), K. Helmke(Universität Hamburg), Stefan Bielack(Olgahospital), U. Heise, Peter Winkler(Paracelsus Medical University), N. Fuchs, H. Jürgens(University of Münster), J. Treuner, Ulrich Exner, R. Kotz(Universität Hamburg), Ralf Romanowski, Nosheen Rehan
Cited by 279
Related Papers
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
|Annals of Oncology|2021|978
Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|751
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
|European Journal of Cancer|2019|724
Osteosarcoma Relapse After Combined Modality Therapy: An Analysis of Unselected Patients in the Cooperative Osteosarcoma Study Group (COSS)
|Journal of Clinical Oncology|2005|654